chrisvoncsefalvay/vaers-outcomes huggingface dataset:
pt recvd vax 5JUL95 & 25JUL95 pt devel a rash & 3 red, raised pruritic lesions on arms & back;same day exp a sl h/a & felt feverish but was afeb;26JUL95 pt had 21 lesions on trunk, face & arms;27JUL95 had 3 or 4 new lesions
chills, muscle and joint pain, fever and fatigue.  Went to bed when it started spent the night in bed and most of the next day I slept.  Slept the second night by Tuesday morning the chills left and most of the muscle aches.  Rested most of the day on Tuesday. First 2 covid  vaccines  I no side effects at all but the booster shot was different.
This report describes the occurrence of an injection site reaction in a 9-year-old male who was vaccinated with hepatitis B vaccine recombinant (Engerix-B) for prophylaxis. This report was received from the pt's mother and has not been verified by a physician or other health care professional. Concurrent conditions and concurrent medications were not reported. The pt reportedly had no allergies. The pt's brother reportedly experienced swollen liver, elevated bilirubin, fatigue, muscle pain and joint pain following receipt of his 1st injection of Engerix-B. On 09/17/2002, the pt reportedly received his 1st injection of Engerix-B (lot ENG5313A2). The mother stated that "after twenty-four hours", on 09/18/2002, her son experienced an injection site reaction characterized by redness, inflammation, itching and tightness. The pt was seen by the physician, who prescribed a "topical steroid cream" and amoxicillin. The events resolved on an unspecified date. The Engerix-B immunization series was discontinued. This report has been linked to report A0387553A due to same family.
This spontaneous report was received from a medical assistant and refers to a patient of unknown age and gender. No information regarding the patient's pertinent medical history, concomitant medications, drug reactions or allergies was provided. On 30-AUG-2018, the patient was vaccinated with a dose of M-M-R II, lot # N009171 and expiration date: 20-MAR-2019 (exact dose, frequency and route of administration were not reported). On 14-SEP-2018, the was vaccinated with a dose of VARIVAX, lot # N019127 and expiration date: 22-JUN-2019 (exact dose, frequency and route of administration were not reported). Both vaccines were reconstituted with properly stored sterile diluent. No adverse effect was reported. No causality assessment was provided.
Patient experience shoulder pain for more than 3 days that made it difficult to sleep or would even wake her up at night. Also made her limit use of that arm. She took ibuprofen. She will be calling to inform her doctor and will call back to the pharmacy in regards to the outcome.
Client advises she had her first Covid 19 Vaccine on 3/16/21. On 3/19/21 Client woke up approx 2am "very itchy, like something crawling all over me, literally". States she went to the bathroom and states she had "all these red spots forming that looked like mosquito bites". States it progressed over time spreading all over her body from face to thighs. States she was living in a group home at the time and they thought it was just related to mosquito bites at first but no one in the house had any bites-states the house is "very clean". Client decided to go on Monday the 22nd to clinic in the city to seek treatment Dr diagnosed client with "allergic reaction to covid vaccine". States the Dr also stated "that means the vaccine is working" but advised her to speak with nurse if she can receive second vaccine as scheduled. Patient advises she is feeling better but not fully recovered at this time. I advised patient that she should not receive second vaccine r/t dx allergic reaction to Covid vaccine.
patient experienced burning sensation, nauseous, weakness few minutes (around 5-10mins.) after receiving shot while seated and in waiting observation area.
Fever over 100, chills, headache that lasted approximately 16 hours; Symptoms relieved with TYLENOL, then ADVIL.
severe flu like symptoms (fever, chills, muscle aches) for two days; redness, swelling, pain, over lg area of injection site since getting injection; meds taken were benadryl, tylenol, ibuprofen
DIED; BLOOD CLOTS; This spontaneous report received from a consumer via social media concerned a male of unspecified age, race and ethnicity. The patient's height, and weight were not reported. The patient's past medical history included: surgery, and other pre-existing medical conditions included: The patient was very healthy. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number: unknown and expiry: unknown) dose, start therapy date were not reported 1 total, dose number series 1, for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported.  On an unspecified date, the patient experienced blood clots. The patient died from unknown cause of death one day after he was forced to take the vaccine. According to reporter patient was very anti vaccine and very healthy. He was there in a rehab from a surgery. It was unspecified if an autopsy was performed. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of blood clots was not reported. This report was serious (Death, and Other Medically Important Condition).; Sender's Comments: V0:20211232634- covid-19 vaccine ad26.cov2.s- Died, Blood clots. This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).; Reported Cause(s) of Death: UNKNOWN CAUSE OF DEATH
Swelling Arm; itchy at the injection site; rash at injection site; Soreness of the injection site; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (Swelling Arm), VACCINATION SITE RASH (rash at injection site), VACCINATION SITE PAIN (Soreness of the injection site) and VACCINATION SITE PRURITUS (itchy at the injection site) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PERIPHERAL SWELLING (Swelling Arm), VACCINATION SITE RASH (rash at injection site), VACCINATION SITE PAIN (Soreness of the injection site) and VACCINATION SITE PRURITUS (itchy at the injection site). At the time of the report, PERIPHERAL SWELLING (Swelling Arm), VACCINATION SITE RASH (rash at injection site), VACCINATION SITE PAIN (Soreness of the injection site) and VACCINATION SITE PRURITUS (itchy at the injection site) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication was not reported. Treatment medication was not reported.    This case was linked to US-MODERNATX, INC.-MOD-2021-090348, US-MODERNATX, INC.-MOD-2021-090495, US-MODERNATX, INC.-MOD-2021-090656 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-090495: US-MODERNATX, INC.-MOD-2021-090348:Crosslinked Case
No adverse event. Staff member said hat because the third shot inn the series was not Bivalent it had to be reported to VAERS. It was given because there was an issue with our shipment of bivalent vaccine. The patient is being notified that he got a monovaent and being offered a bivalent.
2 hours after receiving the COVID vaccine, I experienced the following:  light headedness, dizziness, severe headache, rapid heart rate, high blood pressure, tightness in chest and fatigue
Inappropriate schedule; Tested  for COVID 27Jul2021; Tested  for COVID 27Jul2021; This is a spontaneous report from a contactable consumer. This 22-year-old male consumer (patient) reported for himself. A 22-year-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot Number: ER8732, Expiration date: unknown), via intramuscular, administered in left arm on 26Mar2021 (at the age of 22-year-old) as dose 1, single for COVID-19 immunization. Patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot Number: EW0162, Expiration date: unknown), via intramuscular, administered in left arm on 26Mar2021 (at the age of 22-year-old) as DOSE 2, SINGLE for COVID-19 immunization. The patient medical history and concomitant medications were not reported. Patient was not diagnosed with covid-19 prior vaccination and tested for covid-19 after vaccination. On 27Jul2021, after the vaccination, the patient Tested  for COVID. Lab data includes PCR SARS-CoV-2 test on 26Jul2021 with unknown results and on 27Jul2021 which tested  for covid-19. The outcome of the events was recovering or resolving.  No follow-up attempts possible. No further information expected.  Follow-Up (30Jul2021): Follow-up attempts are completed. No further information is expected.
Chest pain starting on the second day after the second dose. Still occurring as of this submission. Presumed pericarditis after my last appointment with Cardiologist. Colchicine and ibuprofen.
Patient received Modern booster 1 and had sore arm and blood clots after receiving booster.
Patient received Pfizer vaccine on 12/24/21 stated she felt like administration was given to far back from the center of the arm.   During vaccine administration she stated her arm felt numbness all the way down to her fingertips.  She stated when  she got home she noticed injection site was further back then where she is used to getting it and site was bruised.  She reported to us about 2 weeks later she still has some soreness/pain in her arm and has a visible marking were injection site was given.
Rash on arm, shoulder within 24-48 hrs post PPSV 23 administration, was prescribed prednisone,  Pepcid, however, rash resolved spontaneously without medications.  Subsequently developed left upper extremity burning sensation, pain, being evaluated by ortho  CT ortho Dr, given diagnosis of left brachial plexitis. Evaluated by Physiatrist, Dr, scheduled for EMG.  Also scheduled for f/u w/Dr, neurologist.
65 year old patient received the FLUZONE QIV instead of receiving the FLUZONE HIGH DOSE QUADRIVALENT with no reported adverse event; Initial information received on 19-Jan-2022 regarding an unsolicited valid  non-serious case received from a other health professional.  This case involves a 65 years old male patient who received the fluzone qiv instead of receiving the fluzone high dose quadrivalent with no reported adverse event while receiving vaccine INFLUENZA QUADRIVAL A-B VACCINE [FLUZONE QIV].     The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.    On 17-JAN-2022, the patient received a  0.1ml dose of suspect INFLUENZA QUADRIVAL A-B VACCINE lot number not reported via unknown route in unknown administration site for immunization.  On 17-JAN-2022 the patient developed a non-serious event, "65 year old patient received the fluzone qiv instead of receiving the fluzone high dose quadrivalent with no reported adverse event" (wrong product administered) (unknown latency) following the administration of INFLUENZA QUADRIVAL A-B VACCINE.  It was reported, "Nurse is wanting to know if the patient should get revaccinated with the FLUZONE HIGH DOSE QUADRIVALENT."  Action taken with QUADRIVALENT INFLUENZA VACCINE (FLUZONE QIV) was not applicable.  It was not reported if the patient received a corrective treatment for the event (65 year old patient received the FLUZONE QIV instead of receiving the FLUZONE HIGH DOSE QUADRIVALENT with no reported adverse event).  At time of reporting, the outcome was Unknown for the event 65 year old patient received the fluzone qiv instead of receiving the fluzone high dose quadrivalent with no reported adverse event.     This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
11/29/2021 Vaccination. 11/30/2021 I started to feel bad the following day; HA, body aches, dry cough, unsure of fever, joint pain all over. Brain fog. Irritability due to the pain. Difficulty holding a pen and I am an artist. My whole body, my leg, my arm. I will get stuck going to grocery store as it will just hit me. Hurts to take that first step. Hurts my pelvic bone to sit at computer. I can't take the laundry to the laundry room; my sons have to. Aches when I lift up. I have to use the banisters for assistance which I never had to use. Sometimes I even have to crawl up the stairs. It hurts when I stretch, nearly killed me doing some of the yard work; my hands hurt if I do too much. I am also a write but the pain medication is not helping and makes me fall asleep. My lower back, when I sit more for a certain amount of time, its hard to pull myself up. It is hard now to step into the bathtub which was never an issue. I feel anything I do, not in a good way. No diagnosis as of yet. Appt 05/05/2022. I feel frustrated but they are trying.
On 03/18, 11 days after vaccination, pt developed mild macular rash on abdomen. Saw Dr in Employee Health/ER where she works. Diagnosis was contact dermatitis due to having used bleach when laundering clothing. Rash disappeared 2 days later and has not recurred. Pt stopped using the bleach.
Pain in upper back; Heart palpitations; Body aches; Fatigue; This is a spontaneous report from a contactable consumer, the patient. A 56-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: ER8736) via an unspecified route of administration in the left arm on 25Apr2021 at 14:00 (at the age of 56-year-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: ER8737) via an unspecified route of administration on 04Apr2021 (at the age of 56-year-old) as a single dose for COVID-19 immunisation. On 26Apr2021 at 13:30, the patient experienced pain in upper back, heart palpitations, body aches and fatigue. The events did not result in doctor or other healthcare professional office or clinic visit, emergency room or department or urgent care. The clinical outcome of the events pain in upper back, heart palpitations, body aches and fatigue were unknown at the time of this report.  No follow-up attempts are needed. No further information is expected.
Developed symptoms/symptoms were very mild; SARS CoV-2 tested positive; This spontaneous case was reported by a consumer and describes the occurrence of SARS-COV-2 TEST POSITIVE (SARS CoV-2 tested positive) and VACCINATION COMPLICATION (Developed symptoms/symptoms were very mild) in a 74-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history reported.).    On 24-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Feb-2021, the patient experienced SARS-COV-2 TEST POSITIVE (SARS CoV-2 tested positive). On an unknown date, the patient experienced VACCINATION COMPLICATION (Developed symptoms/symptoms were very mild). At the time of the report, SARS-COV-2 TEST POSITIVE (SARS CoV-2 tested positive) had not resolved and VACCINATION COMPLICATION (Developed symptoms/symptoms were very mild) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 30-Jan-2021, SARS-CoV-2 test: Negative. On 05-Feb-2021, SARS-CoV-2 test: (Positive) On 02 Feb 2021, the patient developed symptoms..     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Patient treated with BAM Infusion on 10Feb2021   This case was linked to MOD21-033291 (Patient Link).
After the injection of the vaccine, I started with a headache and my L arm became so sore that by 8pm I could not move it up/down for over 3 days.  The Headache lasted for about 1 week.  I also felt a little sick to my stomach. What has me concern, is that back in October 16, 2020 I had a cardiac cath completed and was found to have only 1 blockage which a stent was immediately put in.  The remaining arties were cleared of any blockages.  I then had the 2 step Pfizer vaccine injections along with the symptoms above.  By March I was still not feeling to where I was having SOB, dizziness and light headed.  I knew something was brewing.  I went to see my cardiologist who in returned scheduled another cardiac cath.  On March 15, 2021 the cath was performed only to find out since the COVID shot, I now have "3" blockages!!  Only 2 stents could be inserted and I remain to this day with a 70% blockage.  I find it very strange that in this short amount of time, that I can become blocked and I believe it has to do with the COVID shot.
Right after receiving the vaccine I didn't really have any adverse effects except tiredness. When I went to my gynecologist appointment they found a 2 inch cyst that was located on my right ovary. I haven't had troubles with cyst before. I have an upcoming follow up appointment on Wednesday for an ultrasound.
Patient took one dose oral typhoid on 6/15/11 about 5pm - about 12 hrs later tingling in knees & bilateral swelling - some improvement on the off day of vaccine - every time she took oral typhoid bilateral knee swelling - persistent swelling until about 7 days after completing oral typhoid. No further swelling since then, no evidence of injury or trauma.
Period 2 weeks early; This spontaneous case was reported by a consumer and describes the occurrence of MENSTRUATION IRREGULAR (Period 2 weeks early) in a 44-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 07-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Jun-2021, the patient experienced MENSTRUATION IRREGULAR (Period 2 weeks early). At the time of the report, MENSTRUATION IRREGULAR (Period 2 weeks early) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant and Treatment medications were not provided by reporter.
I was given shot in left arm. 2 hours later I started to have severe nerve, burning  pain in right mastectomy arm and underarm including my hand, (which I have experienced in the past when I  did a medical procedure and a nurse had mistakenly started IV in my right arm.) On the day of the vaccination  I took voltaren and lyrica and pain subsided after 12 hours , though now August 20, 2021  (4 days later after the vaccination) I am experiencing some light similar pain  again.  A nurse at my medical oncologist's office  had told me when I asked, if the vaccination would be a problem taken in my non-mastectomy arm , and she assured me that it was OK and that only the lymph nodes in the vaccination arm could possibly swell. I am assuming that swelling lymph nodes are what caused this very painful reaction in my non-vaccination arm. I do not have lymphedema and have never had it.
Awoke AM following vaccine with myalgia and subjective fever and chills and shortness of breath. Went to work felt poor. Returned to clinic evaluated by me. Normal CXR and UA. Reported same symptoms above and back pain. Mild HTN/tachycardia improved by end of encounter. Gave Decadron 10 mg and Prednisone. F/U 24 hours.
SWEATS; BODY ACHES/PAIN; SHOOTING ABDOMINAL PAIN BELOW THE RIBS; HEADACHE; NAUSEA; OVERALL FATIGUE; CHILLS; This spontaneous report received from a patient concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805031, and expiry: UNKNOWN) dose was not reported, administered on 19-MAR-2021 at left arm for prophylactic vaccination. No concomitant medications were reported. On 21-MAR-2021, the subject experienced chills. On 05-APR-2021, the subject experienced sweats. On 05-APR-2021, the subject experienced body aches/pain. On 05-APR-2021, the subject experienced shooting abdominal pain below the ribs. On 05-APR-2021, the subject experienced headache. On 05-APR-2021, the subject experienced nausea. On 05-APR-2021, the subject experienced overall fatigue. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from chills on 23-MAR-2021, was recovering from headache, had not recovered from nausea, sweats, and shooting abdominal pain below the ribs, and the outcome of body aches/pain and overall fatigue was not reported. This report was non-serious.
Seems all listed i have now (Soreness at the injection site); Seems all listed i have now (Redness at the injection site); Seems all listed i have now (Itching at the injection site); Seems all listed i have now (Swelling at the injection site); Fever; Seems all listed i have now (myalgia); Seems all listed i have now (fatigue); Seems all listed i have now (headache); Seems all listed i have now (shivering); Seems all listed i have now (gastrointestinal symptoms); This case was reported by a consumer via call center representative and described the occurrence of injection site pain in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   On 4th December 2019, the patient received Shingrix. In December 2019, less than a week after receiving Shingrix, the patient experienced injection site pain, injection site erythema, injection site itching, injection site swelling, fever, myalgia, fatigue, headache, shivering and gastrointestinal symptom nos. On an unknown date, the outcome of the injection site pain, injection site erythema, injection site itching, injection site swelling, fever, myalgia, fatigue, headache, shivering and gastrointestinal symptom nos were unknown.   It was unknown if the reporter considered the injection site pain, injection site erythema, injection site itching, injection site swelling, fever, myalgia, fatigue, headache, shivering and gastrointestinal symptom nos to be related to Shingrix.  Additional case details were reported as follows: The age group was not reported, but was selected adult as per vaccine indication. The patient had vaccine on day before reporting. The patient asked whether he or she could take any over the counter medications for the fever. The patient reported it had been 24 hrs. hours at the time of reporting. The patient seems to have all listed events of the agency. The permission to follow up was denied.